Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Phosphodiesterase Inhibitors, Hardback Book

Phosphodiesterase Inhibitors Hardback

Part of the Handbook of Immunopharmacology series

Hardback

Description

Non-selective inhibitors of cyclic nucleotide phosphodiesterase (PDE), such as theophylline, have been used extensively since 1958.

In the decade of the '70s, various PDE isoenzymes were defined which led to the development of the second generation of PDE inhibitors.

Currently a variety of these new inhibitors are under test as potential anti-inflammatory drugs.

During the past five years, molecular biology has revealed a superfamily of these phosphodiesterase isoenzymes.

This book summarizes the present state of knowledge, as well as giving a comprehensive description of the compounds available.

It will be invaluable for everyone who wants to choose the most suitable PDE inhibitor for their research or who is dealing with such drugs in a clinical setting.

Information

Information

Also in the Handbook of Immunopharmacology series  |  View all